MCK logo

MCK
Mckesson Corporation

3,969
Mkt Cap
$90.72B
Volume
647,090.00
52W High
$999.00
52W Low
$637.00
PE Ratio
19.62
MCK Fundamentals
Price
$763.34
Prev Close
$754.68
Open
$752.60
50D MA
$841.06
Beta
0.08
Avg. Volume
775,419.55
EPS (Annual)
$38.37
P/B
-41.70
Rev/Employee
$9.38M
$113,275.18
Loading...
Loading...
News
all
press releases
What Makes McKesson Corporation (MCK) an Attractive Bet?
What Makes McKesson Corporation (MCK) an Attractive Bet...
Yahoo! Finance: News·1d ago
News Placeholder
More News
News Placeholder
McKesson Corporation (MCK) Highlights Resilience as Its Core Drug Distribution Network Stands the Test of Time
McKesson Corporation (MCK) Highlights Resilience as Its Core Drug Distribution Network Stands the Test of Time...
Yahoo! Finance: News·3d ago
News Placeholder
McKesson Corporation (MCK) Surged 50% on Strong Earnings Growth and Resilient Drug Distribution Model
McKesson Corporation (MCK) Surged 50% on Strong Earnings Growth and Resilient Drug Distribution Model...
Yahoo! Finance: News·3d ago
News Placeholder
CAH Stock Down Nearly 9.4% YTD: Should You Buy, Hold or Sell?
CAH shares are down 9.4% YTD, but strong specialty drug growth, rising earnings estimates and a raised outlook may signal upside.
Zacks·7d ago
News Placeholder
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zacks·7d ago
News Placeholder
Can CAH Sustain Growth on Booming Pharmaceutical & Specialty Segment?
Cardinal Health's Pharmaceutical & Specialty segment posts strong Q3 growth, but can specialty momentum continue powering earnings?
Zacks·8d ago
News Placeholder
McKesson (MCK) Q4 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·13d ago
News Placeholder
MCK Stock Falls Despite Q4 Earnings Beat, Sales Miss, Margins Up
McKesson beats Q4 EPS estimates as oncology and specialty distribution growth offset revenue miss and lift segment margins.
Zacks·13d ago
News Placeholder
Compared to Estimates, McKesson (MCK) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for McKesson (MCK) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·14d ago
News Placeholder
McKesson (MCK) Surpasses Q4 Earnings Estimates
McKesson (MCK) delivered earnings and revenue surprises of +1.14% and -5.52%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago
<
1
2
...
>

Latest MCK News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.